Ill. Admin. Code tit. 77, § 690.520 - Measles, Suspect, Probable or Confirmed (Reportable by telephone immediately, within three hours, upon initial clinical suspicion or laboratory test)
a) Control of
Case
All cases, including suspect cases, with measles shall isolate themselves at home and shall be excluded from school, work, and child care facilities for at least four days after appearance of the rash.
b) Control of Contacts
1) All susceptible contacts (persons six
months of age or older who have not yet received a total of two doses of
measles-containing vaccine) and who have no contraindications to receiving the
vaccine) should begin vaccination with live virus measles vaccine. Vaccine
should be administered within 72 hours after exposure for maximal protection.
When vaccine is given prior to the first birthday, a second dose shall be given
on or after the first birthday, and a third dose at least 28 days later but
prior to school entry (four to six years of age).
2) Susceptible contacts with high risk of
severe illnesses or complications or with measles vaccine contraindications
should be given immune globulin (IG) within six days after exposure. IG is not
indicated for contacts who have received one dose of vaccine at 12 months of
age or older unless they are immunocompromised. Live measles vaccine shall be
given five to six months later to those IG recipients, provided that the
vaccine is not contraindicated.
3)
Susceptible contacts who have not received vaccination within the appropriate
time frame shall be excluded from school, workplace, child care facility, or
other facilities until 21 days after last exposure to a measles case.
4) Susceptible contacts receiving IG as
post-exposure prophylaxis shall isolate themselves at home and shall be
excluded from school, work, and child care facilities for at least 21 days
after the last exposure to a measles case. Local health authorities may
increase this period of exclusion to 28 days if investigation warrants
additional measures to prevent further spread of the disease.
5) Health care personnel with direct patient
contact shall be required to provide proof of immunity to measles as described
by the Advisory Committee on Immunization Practices (see Section
690.20(a)(7)).
6) Susceptible health care workers exposed to
measles shall receive a dose of measles-mumps-rubella (MMR) vaccine and shall
be removed from all patient contact and excluded from the facility from the
fifth to the 21st day after the exposure.
Susceptible health care workers may return to work on the
22nd day after exposure. Regardless of vaccination
history, personnel who become ill with prodromal symptoms or rash shall be
removed from all patient contact and excluded immediately from the facility
until four days after the onset of the rash.
7) Local health authorities, in consultation
with the Department, may require additional exclusions if there is reason to
believe these recommendations will prevent further spread of the disease. (See
Section 2310-15 of the Department of Public Health Powers and Duties
Law)
c) Laboratory
Testing and Reporting
1) Laboratories shall
report to the local health authority any request for measles diagnostic
testing, including molecular (PCR) testing and measles IgM, immediately, within
three hours. Confirmatory (PCR) testing for measles shall be conducted at IDPH
Public Health Laboratories.
2)
Laboratories shall report to the local health authority patients who have a
positive result on any laboratory test indicative of and specific for detecting
measles virus infection.
3)
Laboratories shall forward clinical materials that are PCR positive for measles
to the Department's laboratory.
Upon request, laboratories
performing PCR testing shall forward specimens with Not Detected results for
measles to the Department's laboratory.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.